Related articles

Experts share their insights on different health topics and how comprehensive healthcare solutions can treat different conditions to improve patient health.

Intralipid and its role in cancer patients: cancer nutritional support and weight management

Intralipid is an intravenous nutritional supplement composed primarily of soybean oil, egg yolk lecithin, glycerol, and water. It was originally developed for patients who require intravenous nutrition and is intended to provide essential fatty acids to patients who are unable to obtain nutrition orally. and heat. In recent years, the application of Intralipid in oncology has gradually attracted attention, especially showing potential in helping cancer patients cope with severe weight loss and muscle wasting (i.e. cancer cachexia). For these patients, Intralipid not only stabilizes weight and maintains energy levels, but also supports the body in resisting the side effects of treatment. This article will explore the role of Intralipid in cancer nutrition support and weight management, its potential benefits, and related research.

Read More »

Populations at high risk of heavy metal exposure: the importance of understanding risks and health management

Heavy metal exposure is a root cause of many health problems, and its potential effects may accumulate over time, leading to chronic conditions such as neurological damage, cardiovascular diseases, and even certain cancers. For some specific groups of people, the risk of heavy metal exposure is higher, and these groups need to pay special attention to their health status and take necessary measures to reduce potential risks.

Read More »

Immunotherapy: cutting-edge technologies and applications in cancer care

Immunotherapy has become a breakthrough approach in cancer care, offering new hope for patients by utilizing the body’s immune system to fight cancer. Unlike traditional chemotherapy or radiotherapy, immunotherapy focuses on enhancing the immune system’s ability to recognize and destroy cancer cells. This article will explore the basic principles of immunotherapy, various treatment methods, and its application in cancer management, as well as how testing can help assess the status of the immune system for more accurate treatment decisions.

Read More »

Cancer care: the potential of alternative complementary therapies

As the exploration of cancer care methods continues, more patients and healthcare providers are seeking options beyond traditional treatments. Alternative therapies, such as natural therapies and Gerson therapy, have attracted significant attention because they can, in some cases, serve as complementary approaches that enhance the effectiveness of cancer care, reduce side effects, and improve patients’ quality of life. This article will explore the basic concepts, mechanisms, and potential roles of natural therapies and Gerson therapy in cancer care.

Read More »

Exploring the Potential Role of VascuStatin in Cancer Care

VascuStatin is a natural peptide derived from the prolactin precursor protein, gaining attention in the field of oncology due to its potential anti-angiogenic properties. Anti-angiogenesis refers to the process of inhibiting the formation of new blood vessels in tumors, thereby weakening the tumor’s nutrient supply and growth potential. This article explores the potential applications of VascuStatin in cancer care, as well as key findings from experimental and clinical research.

Read More »

Onco-D-clare: Accurate and personalized cancer risk screening tool

Cancer is a multifactorial disease influenced by genetic, environmental, and lifestyle factors. With advancements in molecular biology and genetic technologies, personalized medicine is becoming a cornerstone of early cancer detection and management. Onco-D-clare, an advanced cancer risk assessment tool, integrates genetic data analysis and molecular diagnostics to provide a comprehensive understanding of individual cancer risks. This article explores the principles, applications, and potential impact of Onco-D-clare on cancer risk management.

Read More »

Air Pollution PM2.5: Cancer Risk and Everyday Protection

PM2.5 (particulate matter less than 2.5 micrometers in diameter) refers to tiny airborne particles that can penetrate deep into the lungs and even enter the bloodstream. These minuscule particles, primarily originating from vehicle emissions, industrial activities, and household combustion, are a major health concern. Long-term exposure to PM2.5 has been linked to various health issues, including respiratory diseases, cardiovascular diseases, and cancer. In recent years, growing evidence suggests a significant association between PM2.5 exposure and the development of certain types of cancer, particularly lung cancer, bladder cancer, and colorectal cancer.

Read More »

Common Enemy: The Interwoven Risks of Cardiovascular Diseases and Cancer

Cardiovascular diseases (CVD) and cancer are two of the most significant health threats in modern society. These two diseases often influence each other and present a substantial shared risk of co-occurrence globally. Although they have different pathological mechanisms and clinical manifestations, the intersection between them—especially in terms of risk factors, treatment strategies, and patient outcomes—has garnered increasing attention.

Read More »

How to choose between CTC and ctDNA in cancer detection?

The continuous advancement of cancer detection technology has provided more options for the formulation of precision care and personalized plans. Among them, circulating tumor cells (CTC) and circulating tumor DNA (ctDNA), as two core liquid biopsy technologies, have attracted much attention due to their unique advantages. However, in practical applications, how to choose appropriate detection methods based on the patient’s specific situation and care goals has become a key issue. This article will explore in depth the characteristics, applicable scenarios, and application potential of CTC and ctDNA in cancer care.

Read More »